ST Pharm offers excellent custom manufacturing services as an oligonucleotide and small-molecule API CDMO, meeting clients' high expectations for use in pharmaceutical development in compliance with cGMP requirements. Expanding oligonucleotide production capabilities has become a new growth engine for the future pharmaceutical industry, and building on in-depth knowledge from nucleoside to oligonucleotide manufacturing, ST Pharm has leveraged its know-how into polynucleotide (mRNA) manufacturing, including its STLNP, 5' capping reagent (SmartCap) and phosphoramidite offerings.

No comments available.
Leave your rating & comment